CN100998687B - 一种治疗慢性胃炎的药物组合物及其制备工艺 - Google Patents
一种治疗慢性胃炎的药物组合物及其制备工艺 Download PDFInfo
- Publication number
- CN100998687B CN100998687B CN2007100627840A CN200710062784A CN100998687B CN 100998687 B CN100998687 B CN 100998687B CN 2007100627840 A CN2007100627840 A CN 2007100627840A CN 200710062784 A CN200710062784 A CN 200710062784A CN 100998687 B CN100998687 B CN 100998687B
- Authority
- CN
- China
- Prior art keywords
- solution
- add
- adds
- thin
- medicinal material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 112
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 33
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims description 74
- 238000000034 method Methods 0.000 title claims description 57
- 229940079593 drug Drugs 0.000 title claims description 21
- 239000000463 material Substances 0.000 claims abstract description 101
- 239000000243 solution Substances 0.000 claims description 247
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 204
- 238000012360 testing method Methods 0.000 claims description 128
- 239000003795 chemical substances by application Substances 0.000 claims description 84
- 239000008194 pharmaceutical composition Substances 0.000 claims description 77
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 72
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 68
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 66
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 64
- 238000002360 preparation method Methods 0.000 claims description 62
- 239000000706 filtrate Substances 0.000 claims description 51
- 239000008187 granular material Substances 0.000 claims description 50
- XDQITMCFPPPMBC-TUANDBMESA-N scutelloside Natural products OC[C@H]1O[C@@H](O[C@@H]2O[C@@H]3C[C@H]4[C@H](O)[C@@H](O)[C@@](O)(CO3)[C@@H]24)[C@H](O)[C@@H](O)[C@@H]1O XDQITMCFPPPMBC-TUANDBMESA-N 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 239000002775 capsule Substances 0.000 claims description 49
- 239000013558 reference substance Substances 0.000 claims description 49
- 241000050051 Chelone glabra Species 0.000 claims description 39
- 239000000843 powder Substances 0.000 claims description 32
- 239000007767 bonding agent Substances 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 24
- 238000004587 chromatography analysis Methods 0.000 claims description 24
- 239000000741 silica gel Substances 0.000 claims description 24
- 229910002027 silica gel Inorganic materials 0.000 claims description 24
- 238000004809 thin layer chromatography Methods 0.000 claims description 24
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 23
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 23
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 23
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 23
- 229910019142 PO4 Inorganic materials 0.000 claims description 22
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 22
- 239000008366 buffered solution Substances 0.000 claims description 22
- 239000000945 filler Substances 0.000 claims description 22
- 239000010452 phosphate Substances 0.000 claims description 22
- 235000019441 ethanol Nutrition 0.000 claims description 21
- 239000006071 cream Substances 0.000 claims description 20
- 238000001816 cooling Methods 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- 239000007921 spray Substances 0.000 claims description 16
- 238000001291 vacuum drying Methods 0.000 claims description 16
- 238000003556 assay Methods 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 11
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 238000004811 liquid chromatography Methods 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 11
- 229910052700 potassium Inorganic materials 0.000 claims description 11
- 239000011591 potassium Substances 0.000 claims description 11
- 238000011003 system suitability test Methods 0.000 claims description 11
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 10
- 239000000890 drug combination Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 9
- YNWAFLRDCQAJNF-UHFFFAOYSA-N O.C(=O)O.CC(=O)C.C(C)(=O)OCC Chemical compound O.C(=O)O.CC(=O)C.C(C)(=O)OCC YNWAFLRDCQAJNF-UHFFFAOYSA-N 0.000 claims description 8
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 8
- ONBIUAZBGHXJDM-UHFFFAOYSA-J bismuth;potassium;tetraiodide Chemical compound [K+].[I-].[I-].[I-].[I-].[Bi+3] ONBIUAZBGHXJDM-UHFFFAOYSA-J 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 8
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 239000001632 sodium acetate Substances 0.000 claims description 8
- 235000017281 sodium acetate Nutrition 0.000 claims description 8
- 239000012085 test solution Substances 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 5
- 229910002114 biscuit porcelain Inorganic materials 0.000 claims description 5
- 229920000609 methyl cellulose Polymers 0.000 claims description 5
- 239000001923 methylcellulose Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 235000008599 Poria cocos Nutrition 0.000 abstract description 12
- 241000405414 Rehmannia Species 0.000 abstract description 12
- 238000003908 quality control method Methods 0.000 abstract description 6
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 238000004886 process control Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 32
- 241000283973 Oryctolagus cuniculus Species 0.000 description 23
- 238000000338 in vitro Methods 0.000 description 23
- 210000000936 intestine Anatomy 0.000 description 22
- 238000002474 experimental method Methods 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 16
- 241000700159 Rattus Species 0.000 description 14
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 12
- 108010061100 Nucleoproteins Proteins 0.000 description 12
- 102000011931 Nucleoproteins Human genes 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 241001647745 Banksia Species 0.000 description 11
- 241001079002 Melicope pteleifolia Species 0.000 description 11
- 241000736199 Paeonia Species 0.000 description 11
- 235000006484 Paeonia officinalis Nutrition 0.000 description 11
- 244000197580 Poria cocos Species 0.000 description 11
- 241000220317 Rosa Species 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 238000012850 discrimination method Methods 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 210000001541 thymus gland Anatomy 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000001575 pathological effect Effects 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 229930003347 Atropine Natural products 0.000 description 7
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 7
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 7
- 229960004373 acetylcholine Drugs 0.000 description 7
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 7
- 229960000396 atropine Drugs 0.000 description 7
- 230000008034 disappearance Effects 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 230000008485 antagonism Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 210000001156 gastric mucosa Anatomy 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 229960001340 histamine Drugs 0.000 description 6
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- ATADHKWKHYVBTJ-FVGYRXGTSA-N (R)-adrenaline hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=C(O)C(O)=C1 ATADHKWKHYVBTJ-FVGYRXGTSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000004100 adrenal gland Anatomy 0.000 description 4
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229960001660 histamine phosphate Drugs 0.000 description 4
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 4
- 229940012189 methyl orange Drugs 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000030136 gastric emptying Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 1
- 108090000143 Mouse Proteins Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- MASVCBBIUQRUKL-UHFFFAOYSA-N POPOP Chemical compound C=1N=C(C=2C=CC(=CC=2)C=2OC(=CN=2)C=2C=CC=CC=2)OC=1C1=CC=CC=C1 MASVCBBIUQRUKL-UHFFFAOYSA-N 0.000 description 1
- 101710106889 Protein glass Proteins 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229960002028 atropine sulfate Drugs 0.000 description 1
- 229940023430 atropine sulfate 0.5 mg/ml Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100627840A CN100998687B (zh) | 2007-01-17 | 2007-01-17 | 一种治疗慢性胃炎的药物组合物及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100627840A CN100998687B (zh) | 2007-01-17 | 2007-01-17 | 一种治疗慢性胃炎的药物组合物及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN100998687A CN100998687A (zh) | 2007-07-18 |
CN100998687B true CN100998687B (zh) | 2011-12-07 |
Family
ID=38257558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100627840A Active CN100998687B (zh) | 2007-01-17 | 2007-01-17 | 一种治疗慢性胃炎的药物组合物及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100998687B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103356798A (zh) * | 2013-07-17 | 2013-10-23 | 南方医科大学 | 治疗慢性胃炎中药在制备防治胃溃疡的药物中的应用 |
CN103463290A (zh) * | 2013-09-10 | 2013-12-25 | 南方医科大学 | 一种防治胃溃疡的口服原位凝胶剂 |
CN106970167A (zh) * | 2017-04-28 | 2017-07-21 | 广西壮族自治区梧州食品药品检验所 | 一种测定两面针牙膏中氯化两面针碱含量的方法 |
-
2007
- 2007-01-17 CN CN2007100627840A patent/CN100998687B/zh active Active
Non-Patent Citations (1)
Title |
---|
中华人民共和国卫生部药典委员会.三九胃泰胶囊.《卫生部颁药品标准(中药成方制剂第十五册)》.1998,6. * |
Also Published As
Publication number | Publication date |
---|---|
CN100998687A (zh) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101274025B (zh) | 一种具有清热泻火解毒作用的中药组合物的质量控制方法 | |
CN102657823A (zh) | 一种具有抗癌作用的中药组合物及其制备方法和检测方法 | |
CN1931236B (zh) | 一种由丹参和红景天制成的药物组合物 | |
CN105169105A (zh) | 具有抗肿瘤、滋阴养胃、增强免疫力功能的中药制剂及其制备方法 | |
CN101773561B (zh) | 一种具有补肾、活血、止痛的中药组合物及其制备方法 | |
CN103028065B (zh) | 一种紫香益母制剂及其制备方法和检测方法 | |
CN103705754A (zh) | 一种治疗系统性红斑狼疮的中药组合物 | |
CN102305839A (zh) | 宣肺平喘的中药组合物的检测方法 | |
CN100998687B (zh) | 一种治疗慢性胃炎的药物组合物及其制备工艺 | |
CN1943757B (zh) | 一种治疗偏头痛的中药组合物及其制备方法 | |
CN101947274B (zh) | 具有抗菌消炎作用的中药组合物的检测方法 | |
CN102288701B (zh) | 宣肺平喘的中药组合物的检测方法 | |
CN1887324B (zh) | 一种治疗肝肾不足的中药组合物及其制备方法和分析方法 | |
CN101933996B (zh) | 一种具有清热泻火解毒作用的中药组合物及其制备方法和检测方法 | |
CN1985873B (zh) | 甘草酸或其盐、人参和黄芪的药物组合物 | |
CN101011543B (zh) | 一种新的抗肿瘤药物组合物 | |
CN101049355B (zh) | 一种由红花与山楂叶制成的药物组合物 | |
CN100482266C (zh) | 一种由肿节风和白花蛇舌草制成的药物组合物 | |
CN100475241C (zh) | 炎可宁药物制剂及其制备方法 | |
CN1961898A (zh) | 一种复方半枝莲抗肿瘤药物组合物及其制备方法 | |
CN102652774A (zh) | 一种治疗放化疗引起的白细胞减少症、免疫功能低下药物组合物、制备方法与质量检测方法 | |
CN102349956B (zh) | 一种润燥止痒复方的提取物及其制剂 | |
CN100534476C (zh) | 由板蓝根和射干制成的药物组合物及其制备方法和用途 | |
CN104547514A (zh) | 治疗系统性红斑狼疮合并血管炎的中药组合物及其用途 | |
CN101190254B (zh) | 葛根或其提取物与瓜蒌或其提取物的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Ma Penggang Document name: Notification that Application Deemed not to be Proposed |
|
C56 | Change in the name or address of the patentee |
Owner name: CHINA RESOURCES SANJIU MEDICAL + PHARMACEUTICAL CO Free format text: FORMER NAME: SANJIU PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Shenzhen Yinhu North Central Avenue of Guangdong province 518029 City 1028 No. 39 group 39 Technology Center Patentee after: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Address before: Shenzhen Yinhu North Central Avenue of Guangdong province 518029 City 1028 No. 39 group 39 Technology Center Patentee before: Sanjiu Pharmaceutical Co., Ltd. |
|
CI01 | Correction of invention patent gazette |
Correction item: Patentee Correct: Sanjiu Pharmaceutical Co., Ltd.|Shenzhen Yinhu North Central Avenue of Guangdong province 518029 City 1028 No. 39 group 39 Technology Center False: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.|Shenzhen Yinhu North Central Avenue of Guangdong province 518029 City 1028 No. 39 group 39 Technology Center Number: 36 Volume: 28 |
|
ERR | Gazette correction |
Free format text: CORRECT: PATENTEE; FROM: CHINA RESOURCES SANJIU MEDICAL + PHARMACEUTICAL CO., LTD.:518029 SANJIU TECHNOLOGY CENTER, SANJIU GROUP, NO.1028, BEIHUAN AVENUE, YINHU DISTRICT, SHENZHEN CITY, GUANGDONG PROVINCE TO: SANJIU PHARMACEUTICAL CO., LTD.:518029 SANJIU TECHNOLOGY CENTER, SANJIU GROUP, NO.1028, BEIHUAN AVENUE, YINHU DISTRICT, SHENZHEN CITY, GUANGDONG PROVINCE |
|
C56 | Change in the name or address of the patentee |
Owner name: CHINA RESOURCES SANJIU MEDICAL AND PHARMACEUTICAL Free format text: FORMER NAME: SANJIU MEDICAL AND PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 518110 Guanlan high tech Industrial Park, Shenzhen, Guangdong, Baoan District Patentee after: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Address before: Shenzhen Yinhu North Central Avenue of Guangdong province 518029 City 1028 No. 39 group 39 Technology Center Patentee before: Sanjiu Pharmaceutical Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070718 Assignee: Huarun 39 (Chenzhou) Pharmaceutical Co., Ltd. Assignor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Contract record no.: 2014440020170 Denomination of invention: Medicine composition for treating chronic gastritis, and its preparing process Granted publication date: 20111207 License type: Exclusive License Record date: 20140521 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Huarun 39 (Chenzhou) Pharmaceutical Co., Ltd. Assignor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Contract record no.: 2014440020170 Date of cancellation: 20170407 |